Bms Ox40

Melanoma: What else beyond Checkpoint Inhibitor pathway ?

Melanoma: What else beyond Checkpoint Inhibitor pathway ?

Read more
Mitigating the toxic effects of anticancer immunotherapy

Mitigating the toxic effects of anticancer immunotherapy

Read more
My Oncologia - Sobrevivência a longo prazo no CPCNP

My Oncologia - Sobrevivência a longo prazo no CPCNP

Read more
Patent US 9,975,957 B2

Patent US 9,975,957 B2

Read more
Bristol-Myers Squibb - organic-reaction com

Bristol-Myers Squibb - organic-reaction com

Read more
Avelumab filed, Pfizer and Merck prepare to join

Avelumab filed, Pfizer and Merck prepare to join

Read more
Bristol-Myers Squibb (BMY) Investor Presentation - Slideshow

Bristol-Myers Squibb (BMY) Investor Presentation - Slideshow

Read more
Second- and third-generation drugs for immuno-oncology

Second- and third-generation drugs for immuno-oncology

Read more
The immunobiology of CD27 and OX40 and their potential as

The immunobiology of CD27 and OX40 and their potential as

Read more
Immunotherapy strategies currently under investigation in BC

Immunotherapy strategies currently under investigation in BC

Read more
Preclinical and Translational Immuno-Oncology - Immuno

Preclinical and Translational Immuno-Oncology - Immuno

Read more
JP Morgan Healthcare Conference

JP Morgan Healthcare Conference

Read more
Unique Immunotherapy Combinations Provide an Optimistic

Unique Immunotherapy Combinations Provide an Optimistic

Read more
Effects of agonist OX40 Ab/vaccine and anti–PD-1 on tumor

Effects of agonist OX40 Ab/vaccine and anti–PD-1 on tumor

Read more
Frontiers | Immunomodulation of the Tumor Microenvironment

Frontiers | Immunomodulation of the Tumor Microenvironment

Read more
Daniel P  Petrylak | New Targets for Advanced Bladder Cancer

Daniel P Petrylak | New Targets for Advanced Bladder Cancer

Read more
Researchers Getting Smarter About Pairing Cancer Treatments

Researchers Getting Smarter About Pairing Cancer Treatments

Read more
Defining the Immune Checkpoint Landscape in Patients (pts

Defining the Immune Checkpoint Landscape in Patients (pts

Read more
Bms Ox40

Bms Ox40

Read more
WO 2017/046746 A1 - Therapeutic Combinations Of A Btk

WO 2017/046746 A1 - Therapeutic Combinations Of A Btk

Read more
Full text] Immune checkpoint inhibitors for small cell lung

Full text] Immune checkpoint inhibitors for small cell lung

Read more
1605 Curti

1605 Curti

Read more
PDF] Intratumoral immunization: a new paradigm for cancer

PDF] Intratumoral immunization: a new paradigm for cancer

Read more
DRS/A

DRS/A

Read more
Next generation of immune checkpoint therapy in cancer: new

Next generation of immune checkpoint therapy in cancer: new

Read more
Clonal expansion of CD8 T cells in the systemic circulation

Clonal expansion of CD8 T cells in the systemic circulation

Read more
WO 2013/043569 A1 - Synergistic Anti-tumor Efficacy Using

WO 2013/043569 A1 - Synergistic Anti-tumor Efficacy Using

Read more
Immuno Oncology Checkpoint Proteins | OriGene

Immuno Oncology Checkpoint Proteins | OriGene

Read more
INTERACTIONS

INTERACTIONS

Read more
EX-99 1

EX-99 1

Read more
AgonOx Medimmune (MEDI 6383) immunotherapy OX40

AgonOx Medimmune (MEDI 6383) immunotherapy OX40

Read more
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer

An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer

Read more
COMPANY PRESENTATION

COMPANY PRESENTATION

Read more
1605 Curti

1605 Curti

Read more
Pharmaceutical R&D Pipeline - Bristol-Myers Squibb

Pharmaceutical R&D Pipeline - Bristol-Myers Squibb

Read more
Thrombocytopenia disease: Malacards - Research Articles

Thrombocytopenia disease: Malacards - Research Articles

Read more
Emerging Immuno-Oncology Therapies: Life After Checkpoint

Emerging Immuno-Oncology Therapies: Life After Checkpoint

Read more
Industry pursues co-stimulatory receptor immunomodulators to

Industry pursues co-stimulatory receptor immunomodulators to

Read more
Advances in Cancer Immunotherapy for Solid Tumors: Expert

Advances in Cancer Immunotherapy for Solid Tumors: Expert

Read more
Bms Ox40

Bms Ox40

Read more
Bms Ox40

Bms Ox40

Read more
For analyst certification and disclosures please see page 9

For analyst certification and disclosures please see page 9

Read more
OX40 Protein - ACROBiosystems

OX40 Protein - ACROBiosystems

Read more
Frontiers | On the Other Side: Manipulating the Immune

Frontiers | On the Other Side: Manipulating the Immune

Read more
Distinct Immune Cell Populations Define Response to Anti-PD

Distinct Immune Cell Populations Define Response to Anti-PD

Read more
What to Do When Anti–PD-1 Therapy Fails in Patients With

What to Do When Anti–PD-1 Therapy Fails in Patients With

Read more
CTLA-4 Antibodies: New Directions, New Combinations : Page 2

CTLA-4 Antibodies: New Directions, New Combinations : Page 2

Read more
Immuno-oncology – Key themes for 2014 | Open Reading Frame

Immuno-oncology – Key themes for 2014 | Open Reading Frame

Read more
Posters & Presentations | Verastem Oncology

Posters & Presentations | Verastem Oncology

Read more
On the Horizon: Immuno-Oncology (I-O) Combinations

On the Horizon: Immuno-Oncology (I-O) Combinations

Read more
Immunomodulators targeting the PDâ•'1/PDâ•'L1 proteinâ

Immunomodulators targeting the PDâ•'1/PDâ•'L1 proteinâ

Read more
Frontiers | Radio-Immunotherapy-Induced Immunogenic Cancer

Frontiers | Radio-Immunotherapy-Induced Immunogenic Cancer

Read more
The future of cancer treatment: immunomodulation, CARs and

The future of cancer treatment: immunomodulation, CARs and

Read more
Full text] Immune checkpoint inhibitors for small cell lung

Full text] Immune checkpoint inhibitors for small cell lung

Read more
Epigenetic modifiers in immunotherapy: a focus on checkpoint

Epigenetic modifiers in immunotherapy: a focus on checkpoint

Read more
CD137: An Important Target in T Cell Co-Stimulation

CD137: An Important Target in T Cell Co-Stimulation

Read more
Rational combination of cancer immunotherapy in melanoma

Rational combination of cancer immunotherapy in melanoma

Read more
Researchers Getting Smarter About Pairing Cancer Treatments

Researchers Getting Smarter About Pairing Cancer Treatments

Read more
알림/공지사항 | (재)범부처신약개발사업단

알림/공지사항 | (재)범부처신약개발사업단

Read more
Clinical Development of Immunostimulatory Monoclonal

Clinical Development of Immunostimulatory Monoclonal

Read more
Blockade of CD134 (OX40)-CD134L interaction ameliorates

Blockade of CD134 (OX40)-CD134L interaction ameliorates

Read more
The evolving landscape of 'next-generation' immune

The evolving landscape of 'next-generation' immune

Read more
ALLIGATOR BIOSCIENCE AB (PUBL)

ALLIGATOR BIOSCIENCE AB (PUBL)

Read more
Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy

Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy

Read more
05_Immune_checkpoints_Curioni A

05_Immune_checkpoints_Curioni A

Read more
Scientific rationale for immunotherapy in lymphoma and

Scientific rationale for immunotherapy in lymphoma and

Read more
Immune-Mediated Treatment in Head and Neck Cancer

Immune-Mediated Treatment in Head and Neck Cancer

Read more
WO 2016/183071 A1 - Hetero-tricyclic Compounds And Their Use

WO 2016/183071 A1 - Hetero-tricyclic Compounds And Their Use

Read more
1605 Curti

1605 Curti

Read more
Frontiers | Immune Checkpoint in Glioblastoma: Promising and

Frontiers | Immune Checkpoint in Glioblastoma: Promising and

Read more
Oncotarget | Altered follicular helper T cell impaired

Oncotarget | Altered follicular helper T cell impaired

Read more
Perspectives in immunotherapy: meeting report from the

Perspectives in immunotherapy: meeting report from the

Read more
On the Horizon: Immuno-Oncology (I-O) Combinations

On the Horizon: Immuno-Oncology (I-O) Combinations

Read more
Frontiers | Progresses and Perspectives of Anti-PD-1/PD-L1

Frontiers | Progresses and Perspectives of Anti-PD-1/PD-L1

Read more
Pfizer's cancer drug combination trials with immunotherapy

Pfizer's cancer drug combination trials with immunotherapy

Read more
The Future of Cancer Care: Observations from the Society for

The Future of Cancer Care: Observations from the Society for

Read more
OX40 Is a Potent Immune-Stimulating Target in Late-Stage

OX40 Is a Potent Immune-Stimulating Target in Late-Stage

Read more
Mologen - Global lefitolimod partnership close to completion

Mologen - Global lefitolimod partnership close to completion

Read more
Tumor-targeted 4-1BB agonists for combination with T cell

Tumor-targeted 4-1BB agonists for combination with T cell

Read more
PATIENT SPECIMEN CLIENT PRIORITY IMMUNE MARKER RESULTS FOR

PATIENT SPECIMEN CLIENT PRIORITY IMMUNE MARKER RESULTS FOR

Read more
05_Immune_checkpoints_Curioni A

05_Immune_checkpoints_Curioni A

Read more
Nat  Rev  Urol  doi: /nrurol - ppt download

Nat Rev Urol doi: /nrurol - ppt download

Read more
Next Generation of Immunotherapy in Oncology | Oncology CME

Next Generation of Immunotherapy in Oncology | Oncology CME

Read more
What to Do When Anti–PD-1 Therapy Fails in Patients With

What to Do When Anti–PD-1 Therapy Fails in Patients With

Read more
On the Horizon: Immuno-Oncology (I-O) Combinations

On the Horizon: Immuno-Oncology (I-O) Combinations

Read more
Bms Ox40

Bms Ox40

Read more
Full text] New modalities of cancer treatment for NSCLC

Full text] New modalities of cancer treatment for NSCLC

Read more
OX40' in Cancer Immunotherapy Review and Collection | Scoop it

OX40' in Cancer Immunotherapy Review and Collection | Scoop it

Read more
Targeting Immunological Synapse: New Horizons in

Targeting Immunological Synapse: New Horizons in

Read more
CD137: An Important Target in T Cell Co-Stimulation

CD137: An Important Target in T Cell Co-Stimulation

Read more
March 2018 – Club SciWri

March 2018 – Club SciWri

Read more
Novel Checkpoints and Cosignaling Molecules in Cancer Immuno

Novel Checkpoints and Cosignaling Molecules in Cancer Immuno

Read more
ASCO 2017

ASCO 2017

Read more
ICOS Promotes the Function of CD4+ Effector T Cells during

ICOS Promotes the Function of CD4+ Effector T Cells during

Read more
Bms Ox40

Bms Ox40

Read more
Immune-Mediated Treatment in Head and Neck Cancer

Immune-Mediated Treatment in Head and Neck Cancer

Read more
What Comes After Immuno-Oncology Therapy for Kidney Cancer

What Comes After Immuno-Oncology Therapy for Kidney Cancer

Read more
Agonists of Co-stimulation in Cancer Immunotherapy Directed

Agonists of Co-stimulation in Cancer Immunotherapy Directed

Read more
New Directions for Immunotherapy in Lung Cancer

New Directions for Immunotherapy in Lung Cancer

Read more
Longer Term Investments

Longer Term Investments

Read more